Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma.
Publication/Presentation Date
1-1-2007
Abstract
Surgical resection provides the only chance for long-term survival for patients diagnosed with pancreatic and other associated periampullary adenocarcinomas. In the past, it had been suggested that the performance of an extended lymphadenectomy in association with a pancreaticoduodenal resection might have improved long-term survival for some patients. In response, six prospective trials have been performed and reported addressing this issue. These studies, including a large randomized trial of 280 patients from Johns Hopkins University, indicate that there is no demonstrable survival benefit to extended lymphadenectomy for periampullary cancer.
Volume
16
Issue
1
First Page
157
Last Page
176
ISSN
1055-3207
Published In/Presented At
Kennedy, E. P., & Yeo, C. J. (2007). Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma. Surgical oncology clinics of North America, 16(1), 157–176. https://doi.org/10.1016/j.soc.2006.10.010
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
17336242
Department(s)
Administration and Leadership
Document Type
Article